CameronR.WolfeMD

Infectious Disease • Durham, NC

Clinical Associate in the Department of Medicine, Duke University School of Medicine

Join to view full profile

Dr. Wolfe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wolfe's full profile

Already have an account?

Office
2301 Erwin Rd
Durham, NC 27705
Phone+1 919-681-9660

Fax+1 919-620-4921

Education & Training

Duke University HospitalFellowship, Infectious Disease, 2007 - 2009
University of Melbourne Faculty of MedicineClass of 2000

Certifications & Licensure

NC State Medical License 2007 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Respiratory Virus Hospitalization Study (FLU 003 Plus) Start of enrollment: 2009 Aug 01
Recruiting
Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
Completed
Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
Completed
Phase 2
Transplantation and the Use of Raltegravir in HIV-Infected Patients Start of enrollment: 2012 Oct 01
Completed
Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 Start of enrollment: 2020 Jun 19
Completed
Phase 2
Immune Modulators for Treating COVID-19 Start of enrollment: 2020 Oct 15
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipie...
Jordan K Mah, Patrick C K Tam, Yeh-Chung Chang, Jennifer H Saullo, Arthur W Baker
Journal of Clinical Virology. 2024-12-13
Deceased Donor Infectious Diseases Testing and Antimicrobial Use: Surveys of Organ Procurement Organizations and Transplant Professionals.
Stephanie M Pouch, Judith A Anesi, Timothy Pruett, Michael Harmon, Sara O Dionne
Transplant Infectious Disease. 2024-11-27
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept.
Madeleine R Heldman, Jennifer L Saullo, Brandon M Menachem, Julia A Messina, Sana Arif
Transplant Infectious Disease. 2024-11-04

Journal Articles

Emergency Use Authorization of Remdesivir
Michael G Ison, Cameron Wolfe, Helen W Boucher, JAMA
Maximizing Utilization of the Donor Pool by Appropriate Classification of Hepatitis C Antibody Positive Donors
Cameron R Wolfe, David S Goldberg, American journal of transplantation

Authored Content

Emergency Use Authorization of RemdesivirMay 2020

Press Mentions

The Mosquito-Borne Virus Raising Alarms in the NortheastAugust 28th, 2024
Hospitals Limit Visitors as Flu Cases Surpass COVIDDecember 28th, 2023
NC Pandemic Response Is Changing. Here’s What the Next Chapter of COVID-19 Looks LikeMay 23rd, 2023
Join now to see all